statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AtriCure Receives Regulatory Approval to Sell AtriClip Devices in China

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management...

AtriCure to Announce Second Quarter 2024 Financial Results

Analyst Ratings For AtriCure

Latest Ratings for ATRC
 DateFirmActionFromTo Feb 2022Canaccord GenuityMaintainsBuy Feb 2022NeedhamMaintainsBuy Nov 2021NeedhamMaintainsBuy
 View More Analyst Ratings for ATRC

 View the...

Atricure's Competitive Landscape Clears: A Buy Rating Amid Delayed Threats and Growth Prospects

Atricure (ATRC Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Michael Matson from Needham...

AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

Cracking The Code: Understanding Analyst Reviews For AtriCure

AtriCure Reports First Quarter 2024 Financial Results

AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management...

AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference

AtriCure Announces Launch of the cryoSPHERE+ Probe for Post-Operative Pain Management

Key Takeaways From AtriCure Analyst Ratings

AtriCure, Inc. engages in the development, manufacture, and sale of surgical ablation of cardiac tissue, and systems for the exclusion of the left atrial appendage. Its products include radio frequency (RF) ablation pacing and sensing, cryo, left atrial appendage management, soft tissue dissection, estech surgical instrumentation, and cart configuration. It operates through the following geographical segments: United States, Europe, Asia, and Other International. The company was founded in 1994 and is headquartered in Mason, OH.

Atricure Inc

Volume	693,923.00
52-Wk High	$57.77
52-Wk Low	$18.94

ATRC Atricure Inc

About

Feed

News

Sentiment

Earnings

Fundamentals